COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 1156: Articles 11551-11560  | Next

Compositional analysis of Sindbis virus ribonucleoproteins reveals an extensive co-opting of key nuclear RNA-binding proteins
Kamel, W., Ruscica, V., Garcia-Moreno, M., Palmalux, N., Iselin, L., Hannan, M., Järvelin, A., Noerenberg, M., Moore, S., Merits, A., Davis, I., Martinez, J., Mohammed, S., Castello, A.
10.1101/2021.10.06.463336 — Posted: 2021-10-08
High-throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain
Dasovich, M. A., Zhou, J., Thomas, A. G., Goodman, J. A., McPherson, R. L., Jayabalan, A. K., Busa, V. F., Cheng, S.-J., Murphy, B., Redinger, K. R., Tsukamoto, T., Slusher, B. S., Bosch, J., Wei, J., Leung, A.
10.1101/2021.10.07.463234 — Posted: 2021-10-07
Monitoring sociodemographic inequality in COVID-19 vaccination coverage in England: a national linked data study
Dolby, T., Finning, K., Baker, A., Dowd, L., Khunti, K., Razieh, C., Yates, T., Nafilyan, V.
10.1101/2021.10.07.21264681 — Posted: 2021-10-07
Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., Milo, R.
10.1101/2021.10.07.21264626 — Posted: 2021-10-07 Discussion: Offsite
TITLE: Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
Quinn, T. M., Gaughan, E. E., Bruce, A., Antonelli, J., O'Connor, R., Li, F., McNamara, S., Koch, O., MacIntosh, C., Dockrell, D., Walsh, T., Blyth, K., Church, C., Schwarze, J., Boz, C., Valanciute, A., Burgess, M., Emanuel, P., Mills, B., Rinaldi, G., Hardisty, G., Mills, R., Findlay, E., Jabbal, S., Duncan, A., Plant, S., Marshall, A. D. L., Young, I., Russell, K., Scholefield, E., Nimmo, A. F., Nazarov, I. B., Churchill, G. C., McCullagh, J. S. O., Ebrahimi, K., Ferrett, C., Templeton, K., Rannard, S., Owen, A., Moore, A., Finlayson, K., Shankar-Hari, M., Norrie, J., Parker, R. A., Akram, A. R., Anthony, D. C., Dear, J. W., Hirani, N., Dhaliwal, K.
10.1101/2021.10.06.21264648 — Posted: 2021-10-07
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination
Garrett, M. E., Galloway, J. G., Wolf, C., Logue, J. K., Franko, N., Chu, H. Y., Matsen, F., Overbaugh, J. M.
10.1101/2021.10.05.463210 — Posted: 2021-10-07
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients
Bassi, J., Giannini, O., Silacci-Fregni, C., Pertusini, L., Hitz, P., Terrot, T., Franzosi, Y., Muoio, F., Saliba, C., Meury, M., Dellota, E., Dillen, J., Hernandez, P., Czudnochowski, N., Cameroni, E., Beria, N., Ventresca, M., Badellino, A., Lavorato-Hadjeres, S., Lecchi, E., Bonora, T., Mattiolo, M., Trinci, G., Garzoni, D., Bonforte, G., Forni-Ogna, V., Giunzioni, D., Berwert, L., Gupta, R. K., Ferrari, P., Ceschi, A., Cippa', P., Corti, D., Lanzavecchia, A., Piccoli, L.
10.1101/2021.10.05.21264054 — Posted: 2021-10-07
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the Comirnaty COVID-19 vaccine in nursing home residents
Sanchez-Sendra, B., Albert, E., Zulaica, J., Torres, I., Gimenez, E., Botija, P., Beltran, M. J., Rodado, C., Geller, R., Navarro, D.
10.1101/2021.10.06.21264607 — Posted: 2021-10-07
Higher Hospitalization and Mortality Rates Among SARS-CoV-2 infected Persons in Rural America
Anzalone, A. J., Horswell, R., Hendricks, B., Chu, S., Hillegass, W., Beasley, W., Harper, J., Rosen, C., Miele, L., McClay, J., Santangelo, S., Hodder, S., N3C Consortium
10.1101/2021.10.05.21264543 — Posted: 2021-10-07 Discussion: Onsite
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty COVID-19 vaccine
Gimenez, E., Alberola, J., Torres, I., Albert, E., Alcaraz, M. J., Botija, P., Amat, P., Remigia, M. J., Beltran, M. J., Rodado, C., Huntley, D., Olea, B., Navarro, D.
10.1101/2021.10.06.21264616 — Posted: 2021-10-07 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).